日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Optimized culturing yields high success rates and preserves molecular heterogeneity, enabling personalized screening for high-grade gliomas.

优化培养可获得较高的成功率并保持分子异质性,从而实现对高级别胶质瘤的个性化筛查

Posthoorn-Verheul Cassandra, Fabro Federica, Ntafoulis Ioannis, den Hollander Chelsea, Verploegh Iris S C, Balvers Rutger, Kers Trisha V, Hoogeveen Jessica, van der Burg Judith, Eussen Bert, de Klein Annelies, Feller Kate J, Chien Miao-Ping, Dirven Clemens M F, Leenstra Sieger, Lamfers Martine L M

Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers

体外药物敏感性筛选可预测胶质母细胞瘤患者对替莫唑胺的反应,并识别候选生物标志物。

Ntafoulis, Ioannis; Kleijn, Anne; Ju, Jie; Jimenez-Cowell, Kevin; Fabro, Federica; Klein, Michelle; Chi Yen, Romain Tching; Balvers, Rutger K; Li, Yunlei; Stubbs, Andrew P; Kers, Trisha V; Kros, Johan M; Lawler, Sean E; Beerepoot, Laurens V; Kremer, Andreas; Idbaih, Ahmed; Verreault, Maite; Byrne, Annette T; O'Farrell, Alice C; Connor, Kate; Biswas, Archita; Salvucci, Manuela; Prehn, Jochen H M; Lambrechts, Diether; Dilcan, Gonca; Lodi, Francesca; Arijs, Ingrid; van den Bent, Martin J; Dirven, Clemens M F; Leenstra, Sieger; Lamfers, Martine L M

Genomic Exploration of Distinct Molecular Phenotypes Steering Temozolomide Resistance Development in Patient-Derived Glioblastoma Cells

基因组学探索调控患者来源胶质母细胞瘤细胞替莫唑胺耐药性发展的不同分子表型

Fabro, Federica; Kers, Trisha V; Feller, Kate J; Beerens, Cecile; Ntafoulis, Ioannis; Idbaih, Ahmed; Verreault, Maite; Connor, Kate; Biswas, Archita; Salvucci, Manuela; Prehn, Jochen H M; Byrne, Annette T; O'Farrell, Alice C; Lambrechts, Diether; Dilcan, Gonca; Lodi, Francesca; Arijs, Ingrid; Kremer, Andreas; Tching Chi Yen, Romain; Chien, Miao-Ping; Lamfers, Martine L M; Leenstra, Sieger